Anxu Life Sciences (688075.SH) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching...
According to the Zhitong Finance APP, Anxu Life Sciences (688075.SH) released the third quarter report for 2024. The company's revenue for the first three quarters was 0.403 billion yuan, a year-on-year increase of 27.56%. The net income attributable to the shareholders of the listed company was 0.136 billion yuan, a year-on-year decrease of 27.33%. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 19.3789 million yuan, a year-on-year decrease of 80.45%. The basic earnings per share was 1.07 yuan per share.